Microcrystalline cellulose is a partially depolymerized cellulose prepared by treating alpha-cellulose, obtained as a pulp from fibrous plant material, with mineral acids. It is commonly used as a diluent, disintegrant, binder and emulsifier in tablet formulations. It improves flow ability and compressibility of powder blends and aids in rapid disintegration and dissolution of tablets post oral administration. The growing pharmaceutical and food & beverage sectors have augmented the demand for microcrystalline cellulose as an excipient in these industries.
The Global Microcrystalline Cellulose Market is estimated to be valued at US$ 1.38 Bn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 To 2031.
Key players
operating in the microcrystalline cellulose are Huzhou City Linghu Xinwang Chemical Co., Ltd., Rayonier Advanced Materials, DFE Pharma, Mingtai Chemical Co., Ltd, JRS Pharma, Asahi Kasei Corporation, Dupont, Avantor Inc., Sigachi Industries Pvt. Ltd, Foodchem International Corporation, Quadra Chemicals, Maple Biotech Pvt. Ltd., Anhui Sunhere Pharmaceutical Excipients Co., Ltd., Accent Microcell Pvt. Ltd., RanQ, Chemfield Cellulose, Roquette Frères, and Sigachi Industries Limited
Growing production of tablets and capsules and an increasing population base consuming pharmaceutical products contribute to the growth of the Microcrystalline Cellulose Market share of in pharmaceutical and food industries has augmented its demand globally
Global expansion - Key manufacturers are expanding their production facilities across regions to leverage growth opportunities. Investments in R&D help improve product quality and drive compliance with stringent regulations of developed markets. Partnerships with pharma companies aid global sales expansion.
Market Key Trends
Microcrystalline cellulose is increasingly utilized as a sustainable and eco-friendly excipient. It is biodegradable and compostable offering advantages over synthetic equivalents. Emphasis on development of green formulations supports use of plant-based excipients like microcrystalline cellulose.
Porter’s Analysis
Threat of new entrants: Low capital requirement and availability of raw materials make entry easy in this market. However, established players dominate capacity and distribution channels creating barriers.
Bargaining power of buyers: Buyers have moderate to high bargaining power as MCC has substitutes and buyers can shift to alternative suppliers easily.
Bargaining power of suppliers: A few MCC manufacturers globally control supply making the bargaining power of suppliers moderate to high.
Threat of new substitutes: Alternatives like starch, gum and gelatin offer substitution threat. However, unique functional properties make alternatives only partial substitutes.
Competitive rivalry: Established global players compete on price and innovation. Dominant players strive to protect market share and expand uses through R&D creating high competition.
Geographical Regions
The region accounts for over 35% of the global market share, as highlighted in the Microcrystalline Cellulose Market Regional Analysis dominates the microcrystalline cellulose market in terms of value owing to a well-established pharmaceutical industry in the US and Canada.
Asia Pacific region is expected to witness the fastest growth during the forecast period due to expansion of pharmaceutical manufacturing bases in India and China. Growing nutraceuticals industry in Japan and Southeast Asia is further driving the demand for MCC in the region.
Discover the language that resonates with you.
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)